Verona Pharma plc reports

Location
3 More London Riverside, London, United Kingdom
State of incorporation
United Kingdom
Fiscal year end
December 31
Data updated at
11/4/2024, 08:48 AM
Form type Sec Links Description Filing date Reporting date
10-Q Report | Data 10-Q Nov 4, 2024 Sep 30, 2024
8-K Report | Data 8-K Nov 4, 2024 Nov 4, 2024
SC 13D/A Report GROWTH EQUITY OPPORTUNITIES FUND IV, LLC / VERONA PHARMA PLC -- SCHEDULE 13DA (# Aug 28, 2024
10-Q Report | Data 10-Q Aug 8, 2024 Jun 30, 2024
8-K Report | Data 8-K Aug 8, 2024 Aug 8, 2024
SC 13G Report SC 13G Jul 29, 2024
SC 13G Report Jul 12, 2024
8-K Report | Data FORM 8-K Jun 27, 2024 Jun 26, 2024
10-Q Report | Data 10-Q May 10, 2024 Mar 31, 2024
8-K Report | Data 8-K May 9, 2024 May 9, 2024
8-K Report | Data FORM 8-K May 9, 2024 May 9, 2024
8-K Report | Data FORM 8-K Apr 30, 2024 Apr 26, 2024
10-K Report | Data 10-K Feb 29, 2024 Dec 31, 2023
8-K Report | Data 8-K Feb 29, 2024 Feb 29, 2024
SC 13G/A Report SC 13G/A Feb 14, 2024
SC 13G/A Report SC 13G/A Feb 14, 2024
SC 13G Report Feb 9, 2024
SC 13G Report SEC SCHEDULE 13G Feb 8, 2024
8-K Report | Data FORM 8-K Feb 2, 2024 Jan 31, 2024
8-K Report | Data FORM 8-K Jan 2, 2024 Dec 27, 2023
8-K Report | Data FORM 8-K Dec 18, 2023 Dec 14, 2023
10-Q Report | Data 10-Q Nov 2, 2023 Sep 30, 2023
8-K Report | Data 8-K Nov 2, 2023 Nov 2, 2023
8-K Report | Data FORM 8-K Sep 11, 2023 Sep 11, 2023
8-K Report | Data FORM 8-K Sep 1, 2023 Aug 28, 2023
10-Q Report | Data 10-Q Aug 3, 2023 Jun 30, 2023
8-K Report | Data 8-K Aug 3, 2023 Aug 3, 2023
SC 13D/A Report AMENDMENT NO. 4 May 16, 2023
10-Q Report | Data 10-Q May 9, 2023 Mar 31, 2023
8-K Report | Data 8-K May 9, 2023 May 9, 2023
8-K Report | Data FORM 8-K May 1, 2023 Apr 27, 2023
SC 13G/A Report SC 13G/A Apr 25, 2023
SC 13G Report SC 13G Apr 20, 2023
10-K Report | Data 10-K Mar 7, 2023 Dec 31, 2022
8-K Report | Data 8-K Mar 7, 2023 Mar 7, 2023
SC 13G/A Report SC 13G/A Feb 14, 2023
SC 13G/A Report AMENDMENT NO. 3 TO SCHEDULE 13G Feb 14, 2023
SC 13G/A Report SC 13G/A Feb 9, 2023
SC 13G/A Report SEC SCHEDULE 13G Feb 6, 2023
SC 13D/A Report AMENDMENT NO. 3 Dec 27, 2022
8-K Report | Data FORM 8-K Dec 20, 2022 Dec 20, 2022
10-Q Report | Data 10-Q Nov 9, 2022 Sep 30, 2022
8-K Report | Data 8-K Nov 9, 2022 Nov 9, 2022
8-K Report | Data FORM 8-K Oct 17, 2022 Oct 14, 2022
SC 13D/A Report GROWTH EQUITY OPPORTUNITIES FUND IV, LLC / VERONA PHARMA PLC -- SCHEDULE 13DA (# Sep 7, 2022
SC 13D/A Report AMENDMENT NO. 2 Aug 12, 2022
8-K Report | Data FORM 8-K Aug 12, 2022 Aug 10, 2022
SC 13D/A Report SC 13D/A Aug 11, 2022
SC 13G/A Report SC 13G/A Aug 10, 2022
8-K Report | Data 8-K Aug 9, 2022 Aug 9, 2022
10-Q Report | Data 10-Q Aug 9, 2022 Jun 30, 2022
10-Q Report | Data 10-Q May 3, 2022 Mar 31, 2022
8-K Report | Data 8-K May 3, 2022 May 3, 2022
8-K Report | Data FORM 8-K Apr 29, 2022 Apr 27, 2022
8-K Report | Data FORM 8-K Mar 30, 2022 Mar 24, 2022
8-K Report | Data FORM 8-K Mar 16, 2022 Mar 14, 2022
10-K Report | Data 10-K Mar 3, 2022 Dec 31, 2021
8-K Report | Data 8-K Mar 3, 2022 Mar 3, 2022
SC 13G/A Report SC 13G/A Feb 14, 2022
SC 13G/A Report AMENDMENT NO. 2 TO SCHEDULE 13G Feb 11, 2022
SC 13G Report SEC SCHEDULE 13G Feb 4, 2022
8-K Report | Data FORM 8-K Jan 5, 2022 Jan 5, 2022
8-K Report | Data 8-K Nov 9, 2021 Nov 9, 2021
10-Q Report | Data 10-Q Nov 9, 2021 Sep 30, 2021
8-K Report | Data FORM 8-K Aug 11, 2021 Aug 9, 2021
8-K Report | Data 8-K Aug 5, 2021 Aug 5, 2021
10-Q Report | Data 10-Q Aug 5, 2021 Jun 30, 2021
8-K/A Report | Data FORM 8-K/A Jul 20, 2021 Jun 9, 2021
8-K Report | Data FORM 8-K Jun 11, 2021 Jun 9, 2021
8-K Report | Data FORM 8-K May 3, 2021 Apr 27, 2021
10-Q Report | Data 10-Q Apr 29, 2021 Mar 31, 2021
8-K Report | Data FORM 8-K Apr 29, 2021 Apr 29, 2021
8-K Report FORM 8-K Mar 2, 2021 Feb 24, 2021
10-K Report | Data 10-K Feb 25, 2021 Dec 31, 2020
8-K Report FORM 8-K Feb 25, 2021 Feb 25, 2021
SC 13G Report SC 13G Feb 16, 2021
SC 13G/A Report AMENDMENT NO. 2 TO SCHEDULE 13G Feb 5, 2021
8-K Report FORM 8-K Jan 25, 2021 Jan 25, 2021
6-K Report FORM 6-K Dec 30, 2020 Dec 1, 2020
6-K Report FORM 6-K Nov 24, 2020 Nov 20, 2020
6-K Report 6-K Nov 12, 2020 Nov 12, 2020
6-K Report 6-K Oct 29, 2020 Sep 30, 2020
SC 13D/A Report SC 13D/A Oct 5, 2020
6-K Report 6-K Sep 25, 2020 Sep 24, 2020
6-K Report 6-K Sep 22, 2020 Sep 22, 2020
6-K Report 6-K Sep 14, 2020 Sep 14, 2020
6-K Report 6-K Aug 27, 2020 Aug 27, 2020
6-K/A Report | Data FORM 6-K/A Aug 25, 2020 Aug 26, 2020
6-K Report 6-K Aug 19, 2020 Aug 19, 2020
6-K Report 6-K Aug 14, 2020 Jun 30, 2020
6-K Report 6-K Aug 10, 2020 Aug 10, 2020
SC 13D/A Report GROWTH EQUITY OPPORTUNITIES FUND IV, LLC / VERONA PHARMA PLC -- SCHEDULE 13DA (# Aug 3, 2020
SC 13D/A Report VERONA PHARMA PLC AMENDMENT NO. 1 Jul 31, 2020
SC 13G Report SC 13G Jul 24, 2020
SC 13D/A Report AMENDMENT NO. 1 TO SCHEDULE 13D Jul 24, 2020
SC 13G/A Report AMENDMENT NO. 1 TO SCHEDULE 13G Jul 24, 2020
6-K Report FORM 6-K Jul 22, 2020 Jul 22, 2020
6-K Report FORM 6-K Jul 20, 2020 Jul 17, 2020
20-F/A Report FORM 20-F/A Jul 16, 2020 Dec 31, 2019
6-K Report 6-K May 14, 2020 May 14, 2020
6-K Report 6-K Apr 30, 2020 Mar 31, 2020
6-K Report 6-K Apr 16, 2020 Apr 16, 2020
6-K Report 6-K Apr 14, 2020 Apr 14, 2020
6-K Report 6-K Apr 6, 2020 Apr 6, 2020
6-K Report 6-K Mar 30, 2020 Mar 20, 2020
6-K Report 6-K Mar 30, 2020 Mar 20, 2020
6-K Report 6-K Mar 10, 2020 Mar 10, 2020
20-F Report | Data 20-F Feb 27, 2020 Dec 31, 2019
SC 13G/A Report SC 13G/A Feb 5, 2020
6-K Report 6-K Feb 4, 2020 Feb 4, 2020
6-K Report 6-K Jan 17, 2020 Jan 16, 2020
6-K Report 6-K Nov 29, 2019 Nov 29, 2019
6-K Report 6-K Nov 22, 2019 Nov 22, 2019
6-K Report 6-K Nov 22, 2019 Nov 22, 2019
6-K Report 6-K Nov 5, 2019 Sep 30, 2019
6-K Report 6-K Sep 19, 2019 Sep 11, 2019
6-K Report 6-K Aug 14, 2019 Aug 14, 2019
6-K Report 6-K Aug 8, 2019 Aug 8, 2019
6-K Report 6-K Aug 7, 2019 Jun 30, 2019
6-K Report 6-K Jun 5, 2019 Jun 4, 2019
6-K Report 6-K May 14, 2019 May 8, 2019
6-K Report 6-K May 7, 2019 Mar 31, 2019
6-K Report 6-K May 3, 2019 May 3, 2019
6-K Report 6-K Apr 12, 2019 Apr 12, 2019
SC 13D Report SC 13D Apr 2, 2019
6-K Report 6-K Mar 26, 2019 Mar 26, 2019
6-K Report 6-K Mar 26, 2019 Mar 26, 2019
20-F Report | Data 20-F Mar 19, 2019 Dec 31, 2018
6-K Report 6-K Mar 12, 2019 Mar 12, 2019
6-K Report 6-K Feb 28, 2019 Feb 1, 2019
SC 13G/A Report SC 13G/A Feb 12, 2019
SC 13G/A Report SC 13G/A Feb 11, 2019
6-K Report 6-K Jan 4, 2019 Jan 4, 2019
6-K Report 6-K Nov 6, 2018 Sep 30, 2018
6-K Report 6-K Sep 25, 2018 Sep 25, 2018
6-K Report 6-K Aug 14, 2018 Aug 31, 2018
6-K Report 6-K Aug 7, 2018 Jun 30, 2018
6-K Report 6-K EGM NOTICE Jun 28, 2018 Jun 28, 2018
6-K Report 6-K Jun 4, 2018 Jun 4, 2018
6-K Report 6-K May 8, 2018 Mar 31, 2018
6-K Report 6-K May 4, 2018 May 31, 2018
6-K Report 6-K May 4, 2018 May 31, 2018
6-K Report 6-K Apr 18, 2018 Apr 1, 2018
6-K Report 6-K Mar 29, 2018 Mar 29, 2018
6-K Report 6-K Mar 22, 2018 Mar 21, 2018
20-F Report | Data 20-F Feb 27, 2018 Dec 30, 2017
SC 13G/A Report SC 13G/A Feb 13, 2018
SC 13G/A Report SC 13G/A Feb 6, 2018
SC 13D/A Report AMENDMENT NO. 1 Jan 26, 2018
6-K Report 6-K Nov 9, 2017 Nov 3, 2017
6-K Report 6-K Sep 21, 2017 Sep 1, 2017
6-K Report 6-K Sep 12, 2017 Sep 8, 2017
6-K Report 6-K Aug 24, 2017 Aug 24, 2017
6-K Report 6-K Aug 8, 2017 Aug 8, 2017
6-K Report 6-K May 26, 2017 May 26, 2017
6-K Report 6-K May 18, 2017 May 18, 2017
SC 13G Report SC 13G May 12, 2017
SC 13D Report VERONA PHARMA PLC -- SCHEDULE 13D May 9, 2017
SC 13G Report SC 13G May 9, 2017
SC 13G Report VERONA PHARMA PLC - SCHEDULE 13G May 8, 2017
SC 13D Report VERONA PHARMA PLC SC 13D May 8, 2017
SC 13D Report SCHEDULE 13D May 8, 2017
SC 13G Report SC 13G May 5, 2017
SC 13G Report SC 13G May 5, 2017
6-K Report 6-K May 3, 2017 May 3, 2017
SC 13G Report SC 13G Feb 13, 2017